Ajanta Pharma Buyback 2022 Record Date, Buyback Price, Entitlement Ratio

Ajanta Pharma Buyback 2022 description – Ajanta Pharma was incorporated on December 31, 1979. The registered and corporate office of the company is situated at Mumbai.

The company is a specialty pharmaceutical formulation player engaged in the development, manufacturing and marketing of qualified finished dosages. The company is focused on the branded generics market in India, Asia and African countries, generics market in USA besides Institutional segment in Africa. The company has seven manufacturing facilities in India out of which two facilities have been approved by US FDA. The company also has a research and development center for finished formulations and active pharmaceutical ingredient synthesis.

Ajanta Pharma Buyback 2022 Details

Buyback Dates	3 – 16 February 2022
Ajanta Pharma Buyback Price	INR2,550 per share
Buyback Offer Size	11,20,000 shares
Buyback offer as % of total shares	1.29%
Offer Amount	INR85.60 crore
Offer Type	Tender
Promoter Participation	Yes
Face Value	INR2 per share
Listing At	BSE, NSE

---

Ajanta Pharma Buyback Dates (Timeline)

Board Meeting for Buyback Proposal	28 December 2021
Buyback Approval Date	28 December 2021
Public Announcement of Buyback	30 December 2021
Ajanta Pharma Buyback Record Date	14 January 2022
Buyback Opening Date	3 February 2022
Buyback Closing Date	16 February 2022
Cut-off Date to receive completed tender forms by Registrar	16 February 2022
Verification Date by the Registrar	24 February 2022
Return of unaccepted shares by Registrar	24 February 2022
Extinguishment of accepted shares	04 March 2022

---

Registrar of Ajanta Pharma Buyback 2022

Link Intime India Private Limited
Address: C 101, 1st Floor, 247 Park, L B S Marg,Vikhroli West
Mumbai – 400 083
Phone: +91 22 4918 6200
Fax: 91 22 4918 6195
Email: [email protected]
Website: www.linkintime.co.in

---

Manager of Ajanta Pharma Buyback 2022

Vivro Financial Services Private Limited
607/608 Marathon Icon, Opp. Peninsula Corporate Park
Veer Santaji Lane, Off. Ganpatrao Kadam Marg, Lower Parel
Mumbai – 400 013
Phone: +91 22 6666 8040
Email: [email protected]
Website: www.vivro.net

---

Ajanta Pharma 2022 Documents

Letter Of Offer
Draft Offer Letter
Public Announcement
Upcoming Share Buyback

Pre-Buyback Shareholding Pattern of Ajanta Pharma

Shareholder Category	No. of shares	% of shares
Promoters	6,08,69,823	70.34
DIIs/MFs	1,08,51,246	12.54
FIIs/FPIs/NRIs	79,88,297	9.23
Bodies corporate	68,26,404	7.89
Grand Total	8,65,35,770	100

---

Ajanta Pharma Buyback Entitlement Ratio

Shareholder Category	Entitlement Ratio	Entitlement Ratio (in %)
Reserved category for Small Shareholders	30/151	19.87
General category for all other Eligible Shareholders	1/91	1.10

Small Shareholder is defined as shareholder who holds shares worth less than INR2,00,000 as on record date.

---

Ajanta Pharma Financial Performance

	FY2019	FY2020	FY2021
Total Income	2,074.5	2,680.1	2,915.7
Total Expenses	1,488.9	1,904.5	1,891.1
Net income	387.0	467.7	647.4
Net Worth	2,245.2	2,598.9	2,995.6

---

Necessity of the Buyback

• The buy-back gives an option to the equity shareholders to participate in the buy-back and receive cash in lieu of Equity Shares accepted under the buy-back.
• The buy-back helps to return surplus cash to its shareholders, in proportion to their shareholding, thereby, enhancing the overall returns to shareholders.
• The buy-back would help in improving Earning per share (EPS), Return on asset (ROA) and Return on equity (ROE) ratios of the Company.
• The buy-back, which is being implemented through the Tender Offer route as prescribed under the Buyback Regulations, would involve a reservation for small shareholders as defined in the Buy-back Regulations.

---

Process to Participate in Ajanta Pharma Buyback

• All eligible shareholders of the company who own physical shares or demat Shares on the record date may participate in the buyback offer through their stock broker. The eligible shareholder who holds the shares in demat form must notify their broker of the details of the equity shares that they wish to tender in the Buyback Offer.

• The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.

• The eligible shareholder who owns the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.

Working Calculation of Amount Invested in Ajanta Pharma Buyback

Maximum market value of a share holder as on record date	INR2,00,000
Buyback price	INR2,550
Maximum shares of a share holder as on record date (2,00,000/2,550)	78 shares
Closing price of share as on record date (14 January 2022)	INR2,306.75
Amount Invested in buyback (2,306.75 x 78 shares)	INR1,79,926

Profit from the Ajanta Pharma buyback by acceptance ratio

Acceptance ratio	Amount invested in buyback	No. of shares buyback	Buyback Profit	Profit in %
33%	1,79,926	26	6,325	3.51
50%	1,79,926	39	9,487	5.27
75%	1,79,926	59	14,352	7.98
100%	1,79,926	78	18,973	10.54

---

Frequently Asked Questions